Evidence map›Paper›PMID 39134632›Full record

ArticleScientific reports2024

Correlation between serum advanced glycation end-products and vascular complications in patient with type 2 diabetes.

Sayuri Kato, Takeshi Matsumura, Hikari Sugawa, Ryoji Nagai

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. [Elevated advanced glycation endproducts is a risk factor for stenosis after primary arteriovenous fistula surgery].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  10. Article
  11. Review
  12. Sanger Sequencing Reveals Novel Variants inMedicina (Kaunas, Lithuania) · 2024
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sayuri KatoLaboratory of Food and Regulation Biology, Graduate School of Bioscience, Tokai University, Kumamoto, Japan.
Takeshi MatsumuraDepartment of Metabolic Medicine, Faculty of Life Science, Kumamoto University, Kumamoto, Japan.
Hikari SugawaLaboratory of Food and Regulation Biology, Department of Food and Life Sciences, School of Agriculture, Tokai University, Sugidoh 871-12, Maschiki-Machi, Kamimashiki-Gun, Kumamoto, 861-2205, Japan.
Ryoji NagaiLaboratory of Food and Regulation Biology, Graduate School of Bioscience, Tokai University, Kumamoto, Japan. nagai-883@umin.ac.jp.

Funding

Japan Society for the Promotion of Science 20K05895Japan Society for the Promotion of Science 23K07533
6 · The paper itself

Abstract

Advanced glycation end-products (AGEs) formation increases with metabolic disorders, leading to higher serum AGE levels in patients with progressive vascular complications. Measuring AGE levels in biological samples requires multiple pre-analytical processing steps, rendering analysis of multiple samples challenging. This study evaluated the progression of diabetic complications by analyzing AGE levels using a pre-analytical processing strategy based on a fully automated solid phase-extraction system. Serum samples from patients with diabetes, with or without macrovascular complications (Mac or non-Mac) or microvascular complications (Mic or non-Mic), were processed with the established methods. Free and total AGE levels in sera were measured using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). In patients with diabetes, both free and total AGE levels were elevated in those with complications compared to those without complications. In Mac and Mic groups, free and total AGE levels and z-scores (the sum of normalized AGE levels) also increased. AGE z-scores were markedly higher than those of single AGE levels in distinguishing each complication. Our study demonstrated that the free AGE z-score, measured using a new analytical method without hydrolysis, correlated with the presence of vascular complications and may serve as a marker of disease complications.

Indexed as

Diabetes Mellitus, Type 2Diabetic AngiopathiesGlycation End Products, AdvancedTandem Mass SpectrometryAgedBiomarkersChromatography, LiquidFemaleHumansMaleMiddle AgedBiomarkersGlycation End Products, AdvancedAdvanced glycation end-productsHealthy life expectancyMass spectrometryType 2 diabetesVascular complications

Identifiers

PMID39134632
PMCPMC11319737

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.